Diane L Wang1, Ali S Raza2, Carlos Gustavo de Moraes3, Monica Chen1, Paula Alhadeff4, Ravivarn Jarukatsetphorn4, Robert Ritch4, Donald C Hood5. 1. Department of Psychology, Columbia University, New York, NY, USA. 2. Department of Psychology, Columbia University, New York, NY, USA ; Department of Neurobiology and Behavior, Columbia University, New York, NY, USA. 3. Department of Ophthalmology, Columbia University, New York, NY, USA. 4. Einhorn Clinical Research Center, New York Eye and Ear Infirmary of Mount Sinai, New York, NY, USA. 5. Department of Psychology, Columbia University, New York, NY, USA ; Department of Ophthalmology, Columbia University, New York, NY, USA.
Abstract
PURPOSE: To assess the extent to which glaucomatous damage of the macula can be detected using the summary statistics of a commercial report based upon the circumpapillary retinal nerve fiber layer (cpRNFL) thickness obtained with frequency domain optical coherence tomography (fdOCT). METHODS: One hundred forty-three eyes of 143 open-angle glaucoma patients and suspects (56.4 ± 13.8 years) had 10-2 visual fields (VFs) and fdOCT macular and disc cube scans. RNFL and retinal ganglion cell plus inner plexiform layer thickness and probability maps were generated and combined with 10-2 VF information in a single-page, custom report previously described. Three graders evaluated these reports and classified each eye as "abnormal macula" or "normal macula." Commercially available fdOCT reports for cpRNFL thickness were generated using the automatic segmentation algorithm and norms from the machine. The ability of the reports to detect macular damage was analyzed in three ways: temporal quadrant (TQ) < 5%; TQ < 5% or clock hour 7 < 1% (TQ + CH7); and clock hours 7 through 10 with two sectors < 5% or one sector < 1% (CH7-10). RESULTS: Sixty-one (43%) eyes were classified "abnormal macula" and 41 (29%) as "normal macula"; the 10-2 VFs and OCT probability maps did not agree in the remaining eyes. Of the 61 abnormal eyes, the TQ criterion missed 47 (77%); TQ + CH7 missed 24 (39%); and CH7-10 missed 22 (36%). CONCLUSIONS: Conventional cpRNFL analyses on commercial OCT reports can miss macular (central field) damage. TRANSLATIONAL RELEVANCE: To detect glaucomatous damage of the macula, additional tests, such as macular cube scans and/or 10-2 VFs, should be performed.
PURPOSE: To assess the extent to which glaucomatous damage of the macula can be detected using the summary statistics of a commercial report based upon the circumpapillary retinal nerve fiber layer (cpRNFL) thickness obtained with frequency domain optical coherence tomography (fdOCT). METHODS: One hundred forty-three eyes of 143 open-angle glaucoma patients and suspects (56.4 ± 13.8 years) had 10-2 visual fields (VFs) and fdOCT macular and disc cube scans. RNFL and retinal ganglion cell plus inner plexiform layer thickness and probability maps were generated and combined with 10-2 VF information in a single-page, custom report previously described. Three graders evaluated these reports and classified each eye as "abnormal macula" or "normal macula." Commercially available fdOCT reports for cpRNFL thickness were generated using the automatic segmentation algorithm and norms from the machine. The ability of the reports to detect macular damage was analyzed in three ways: temporal quadrant (TQ) < 5%; TQ < 5% or clock hour 7 < 1% (TQ + CH7); and clock hours 7 through 10 with two sectors < 5% or one sector < 1% (CH7-10). RESULTS: Sixty-one (43%) eyes were classified "abnormal macula" and 41 (29%) as "normal macula"; the 10-2 VFs and OCT probability maps did not agree in the remaining eyes. Of the 61 abnormal eyes, the TQ criterion missed 47 (77%); TQ + CH7 missed 24 (39%); and CH7-10 missed 22 (36%). CONCLUSIONS: Conventional cpRNFL analyses on commercial OCT reports can miss macular (central field) damage. TRANSLATIONAL RELEVANCE: To detect glaucomatous damage of the macula, additional tests, such as macular cube scans and/or 10-2 VFs, should be performed.
Authors: Donald C Hood; Anastasia Slobodnick; Ali S Raza; Carlos Gustavo de Moraes; Christopher C Teng; Robert Ritch Journal: Invest Ophthalmol Vis Sci Date: 2014-02-03 Impact factor: 4.799
Authors: Donald C Hood; Diane L Wang; Ali S Raza; Carlos Gustavo de Moraes; Jeffrey M Liebmann; Robert Ritch Journal: Invest Ophthalmol Vis Sci Date: 2013-11-08 Impact factor: 4.799
Authors: Felipe A Medeiros; Linda M Zangwill; Christopher Bowd; Roberto M Vessani; Remo Susanna; Robert N Weinreb Journal: Am J Ophthalmol Date: 2005-01 Impact factor: 5.258
Authors: Daiyan Xin; Christine L Talamini; Ali S Raza; Carlos Gustavo V de Moraes; Vivienne C Greenstein; Jeffrey M Liebmann; Robert Ritch; Donald C Hood Journal: Invest Ophthalmol Vis Sci Date: 2011-09-09 Impact factor: 4.799
Authors: Kyung Rim Sung; Gadi Wollstein; Na Rae Kim; Jung Hwa Na; Jessica E Nevins; Chan Yun Kim; Joel S Schuman Journal: Br J Ophthalmol Date: 2012-09-27 Impact factor: 4.638
Authors: Paul H Artes; Balwantray C Chauhan; John L Keltner; Kim E Cello; Chris A Johnson; Douglas R Anderson; Mae O Gordon; Michael A Kass Journal: Arch Ophthalmol Date: 2010-12
Authors: Carlos Gustavo De Moraes; Ashley Sun; Ravivarn Jarukasetphon; Rashmi Rajshekhar; Lynn Shi; Dana M Blumberg; Jeffrey M Liebmann; Robert Ritch; Donald C Hood Journal: JAMA Ophthalmol Date: 2019-02-01 Impact factor: 7.389
Authors: C Gustavo De Moraes; Donald C Hood; Abinaya Thenappan; Christopher A Girkin; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill; Jeffrey M Liebmann Journal: Ophthalmology Date: 2017-05-24 Impact factor: 12.079
Authors: Andrew C Lin; Cecilia S Lee; Marian Blazes; Aaron Y Lee; Michael B Gorin Journal: Transl Vis Sci Technol Date: 2021-05-03 Impact factor: 3.283
Authors: Donald C Hood; Bruna Melchior; Emmanouil Tsamis; Jeffrey M Liebmann; Carlos G De Moraes Journal: J Glaucoma Date: 2021-04-01 Impact factor: 2.290
Authors: Zhichao Wu; Denis S D Weng; Abinaya Thenappan; Robert Ritch; Donald C Hood Journal: Transl Vis Sci Technol Date: 2018-03-29 Impact factor: 3.283
Authors: Ha Min Kim; William E McKee; Katarzyna B Malendowicz; Abinaya A Thenappan; Emmanouil Tsamis; Melvi D Eguia; C Gustavo De Moraes; Robert Ritch; Donald C Hood Journal: J Glaucoma Date: 2020-10 Impact factor: 2.290